Congress Probes Drug Abuse At Weapons Labs

LIVERMORE, CALIF—Officials at the nation's three top-secret nuclear weapons laboratories know that drug use among employees poses an extremely serious security risk. But they don't appear to be doing enough about it. That's the verdict of some members of Congress, who cite a series of seemingly erratic measures the labs have been taking to combat the problem. "If you have someone who's dependent on drugs," says Clifford Traisman, an aide to a House oversight subcommittee that is looking in

Written byVincent Kiernan
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

"If you have someone who's dependent on drugs," says Clifford Traisman, an aide to a House oversight subcommittee that is looking into health and safety issues at the labs, "that person not only won't be able to do his job properly, but he'll also be vulnerable to blackmail. Either way, it's a threat to national security."

Indeed, the numbers suggest that drugs are no less of a problem within the confines of some of the nation's most security-conscious facilities than they are among the general public. Since the beginning of 1986, for example, 174 workers at the Los Alamos National Laboratory in New Mexico have been referred to drug treatment programs, according to Department of Energy spokesman David Jackson. At neighboring Sandia National Laboratory in Albuquerque, 15 employees have been fired in the past 16 years for drug-related problems—a step taken only after the employees failed to respond to individual ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies